Literature DB >> 3113699

Biological characterization of interleukin-1-like cytokine produced by cultured bone cells from newborn mouse calvaria.

S Hanazawa, S Amano, K Nakada, Y Ohmori, T Miyoshi, K Hirose, S Kitano.   

Abstract

We have investigated the role of interleukin-1 (IL-1) and IL-1-like factor in the regulatory mechanisms of a bone remodeling system. To determine whether the bone cell itself produces IL-1-like cytokine, we examined bone cells cultured from newborn mouse calvaria. Bone cells migrating from fragments of newborn mouse calvaria were used in this study. We also used bone cells obtained by consecutive digestion of the calvaria with enzymes. These bone cells were cultured in fetal calf serum-containing alpha-MEM. IL-1-like cytokine activity was measured by incorporation of [3H]thymidine into C3H/HeJ thymocytes stimulated with PHA. When treated with lipopolysaccharide (LPS) from Escherichia coli 0111 B4, the cultured bone cells produced a significant amount of IL-1-like cytokine. The maximum concentration of IL-1-like cytokine was observed in culture supernatants of the bone cells cultured for 24 hours with the LPS in serum-free medium. The IL-1-like cytokine closely resembles IL-1 in some of its biological characteristics: stimulation of mitogen-induced thymocyte proliferation, stimulation of fibroblast proliferation, pyrogenicity, and molecular weight. These results show that cultured bone cells from newborn mouse calvariae produce an IL-1-like cytokine that closely resembles IL-1.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3113699     DOI: 10.1007/bf02555128

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  14 in total

1.  Target cells in bone for parathormone and calcitonin are different: enrichment for each cell type by sequential digestion of mouse calvaria and selective adhesion to polymeric surfaces.

Authors:  G L Wong; D V Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

2.  The effects of monocyte-conditioned medium and interleukin 1 on the synthesis of collagenous and non-collagenous proteins by mouse bone and human bone cells in vitro.

Authors:  J N Beresford; J A Gallagher; M Gowen; M Couch; J Poser; D D Wood; R G Russell
Journal:  Biochim Biophys Acta       Date:  1984-09-07

3.  Epidermal cell (keratinocyte)-derived thymocyte-activating factor (ETAF).

Authors:  T A Luger; B M Stadler; S I Katz; J J Oppenheim
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

4.  Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells.

Authors:  A Fontana; F Kristensen; R Dubs; D Gemsa; E Weber
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

5.  An interleukin 1 like factor stimulates bone resorption in vitro.

Authors:  M Gowen; D D Wood; E J Ihrie; M K McGuire; R G Russell
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

6.  The pyrogenic and mitogenic actions of interleukin-1 are related.

Authors:  G W Duff; S K Durum
Journal:  Nature       Date:  1983 Aug 4-10       Impact factor: 49.962

7.  Functional role of interleukin 1 in periodontal disease: induction of interleukin 1 production by Bacteroides gingivalis lipopolysaccharide in peritoneal macrophages from C3H/HeN and C3H/HeJ mice.

Authors:  S Hanazawa; K Nakada; Y Ohmori; T Miyoshi; S Amano; S Kitano
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

8.  Modulation of connective tissue metabolism by partially purified human interleukin 1.

Authors:  H J Richardson; P R Elford; R M Sharrard; J E Meats; R G Russell
Journal:  Cell Immunol       Date:  1985-01       Impact factor: 4.868

9.  Human interleukin 1 mediates cartilage matrix degradation.

Authors:  T Krakauer; J J Oppenheim; H E Jasin
Journal:  Cell Immunol       Date:  1985-03       Impact factor: 4.868

10.  Biochemical characterization with parathormone and calcitonin of isolated bone cells: provisional identification of osteoclasts and osteoblasts.

Authors:  R A Luben; G L Wong; D V Cohn
Journal:  Endocrinology       Date:  1976-08       Impact factor: 4.736

View more
  9 in total

Review 1.  Bacterially induced bone destruction: mechanisms and misconceptions.

Authors:  S P Nair; S Meghji; M Wilson; K Reddi; P White; B Henderson
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Stimulatory effect on bone resorption of interleukin-1-like cytokine produced by an osteoblast-rich population of mouse calvarial cells.

Authors:  S Amano; S Hanazawa; K Hirose; Y Ohmori; S Kitano
Journal:  Calcif Tissue Int       Date:  1988-08       Impact factor: 4.333

3.  WITHDRAWN: Cardamonin Inhibits Osteoclastogenesis Induced by Tumor Cells Through Interruption of the Signaling Pathway Activated by Receptor Activator of NF-κB Ligand.

Authors:  Vivek R Yadav; Sahdeo Prasad; Simone Reuter; Bokyung Sung; Norio Yamamoto; Akira Murakami; Bharat B Aggarwal
Journal:  Cancer Lett       Date:  2011-12-17       Impact factor: 8.679

4.  Cyclosporines: correlation of immunosuppressive activity and inhibition of bone resorption.

Authors:  P J Stewart; P H Stern
Journal:  Calcif Tissue Int       Date:  1989-10       Impact factor: 4.333

5.  Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide.

Authors:  C Y Chiang; G Kyritsis; D T Graves; S Amar
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

6.  Anti-inflammatory effect of MAPK phosphatase-1 local gene transfer in inflammatory bone loss.

Authors:  H Yu; Q Li; B Herbert; R Zinna; K Martin; C R Junior; K L Kirkwood
Journal:  Gene Ther       Date:  2010-11-11       Impact factor: 5.250

7.  Bone matrix constituents stimulate interleukin-1 release from human blood mononuclear cells.

Authors:  R Pacifici; A Carano; S A Santoro; L Rifas; J J Jeffrey; J D Malone; R McCracken; L V Avioli
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

8.  Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release.

Authors:  R Pacifici; L Rifas; R McCracken; I Vered; C McMurtry; L V Avioli; W A Peck
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

9.  RANKL signaling and osteoclastogenesis is negatively regulated by cardamonin.

Authors:  Bokyung Sung; Sahdeo Prasad; Vivek R Yadav; Subash C Gupta; Simone Reuter; Norio Yamamoto; Akira Murakami; Bharat B Aggarwal
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.